Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Our portfolio of bispecifics has the potential to replace the first-generation checkpoint inhibitors across a range of cancers
Y., Beard, M
Candidates seeking plumper butts and steep curves are more well-suited to BBL, which recontours both the donor and recipient sites to provide volume and projection
When utilising glutathione, no one is harmed, regardless of age
Consumer skepticism and the risk of shallow "GLP-1-friendly" positioning continue to restrain category trust
US$ 21.08
US$ 26.75
US$ 27.22
US$ 28.78
US$ 27.98
US$ 28.00
US$ 29.92
